EUVIMEDEUVIMED entdecken
Open Access

The Role of Anti-BP180 Antibody Monitoring in Bullous Pemphigoid: An Italian Single-Center Experience

Alice Massi, Stephano Cedirian, Giacomo Clarizio, Tullio Brunetti, Alessio Natale, Andrea Gabusi, Federica Filippi, Camilla Loi, Lidia Sacchelli, Michelangelo La Placa, Bianca Maria Piraccini, Federico Bardazzi

Dermatology Practical & Conceptual · 30.04.2026 · 16 (2) · 6854

DOI: 10.5826/dpc.1602a6854 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dermatology Practical & Conceptual, online erschienen am 30.04.2026. Verfasst von Alice Massi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, BolognaItaly. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Bullous pemphigoid (BP) is the most common autoimmune blistering disorder, with anti-BP180 antibodies playing a key role in its pathogenesis and diagnosis. However, their utility in disease monitoring remains debated.

Objectives

This study evaluate the role of anti-BP180 antibody monitoring in BP management through a single-center retrospective analysis and literature review.

Methods

We analyzed 149 BP patients diagnosed between 2014 and 2024 at the Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna. Anti-BP180 titers were measured at baseline, six months, and remission. Therapeutic responses and antibody dynamics were assessed and compared with the literature.

Results

Higher baseline anti-BP180 levels correlated with severe disease and prolonged remission times. A ≥60% reduction in titers was associated with successful therapeutic tapering and lower relapse rates. Patients with secondary BP forms exhibited lower baseline titers and faster remission.

Conclusions

Anti-BP180 monitoring serves as a valuable adjunct to clinical assessment, aiding therapeutic decisions, particularly in determining tapering timelines. Nonetheless, integrated approaches combining serological and clinical evaluations remain essential.

Autor:innen und Institutionen

  • Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, BolognaItaly.
  • Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, BolognaItaly.
  • Section of Oral Sciences, Department of Biomedical and Neuromotor Sciences, University of Bologna, BolognaItaly.

Zitieren

APA

Massi, A., Cedirian, S., Clarizio, G., Brunetti, T., Natale, A., Gabusi, A., Filippi, F., Loi, C., Sacchelli, L., La Placa, M., Piraccini, B. M., & Bardazzi, F. (2026). The Role of Anti-BP180 Antibody Monitoring in Bullous Pemphigoid: An Italian Single-Center Experience. Dermatology Practical & Conceptual, 16(2), 6854. https://doi.org/10.5826/dpc.1602a6854

Vancouver

Massi A, Cedirian S, Clarizio G, Brunetti T, Natale A, Gabusi A, et al. The Role of Anti-BP180 Antibody Monitoring in Bullous Pemphigoid: An Italian Single-Center Experience. Dermatology Practical & Conceptual. 2026;16(2):6854. doi:10.5826/dpc.1602a6854

BibTeX
@article{Massi2026,
  author = {Massi, Alice and Cedirian, Stephano and Clarizio, Giacomo and Brunetti, Tullio and Natale, Alessio and Gabusi, Andrea and Filippi, Federica and Loi, Camilla and Sacchelli, Lidia and La Placa, Michelangelo and Piraccini, Bianca Maria and Bardazzi, Federico},
  title = {The Role of Anti-BP180 Antibody Monitoring in Bullous Pemphigoid: An Italian Single-Center Experience},
  journal = {Dermatology Practical & Conceptual},
  year = {2026},
  volume = {16},
  number = {2},
  pages = {6854},
  doi = {10.5826/dpc.1602a6854}
}
Kostenlos starten →